Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamal Benhamida

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Diagnostic Pathology|June 27, 2019
Validation of mitotic cell quantification via microscopy and multiple whole-slide scannersKazuhiro Tabata, Naohiro Uraoka, Jamal Benhamida, et al.
Genome Research|April 23, 2008
Comparative proteogenomics: combining mass spectrometry and comparative genomics to analyze multiple genomesNitin Gupta, Jamal Benhamida, Vipul Bhargava, et al.
The Journal of Molecular Diagnostics : JMD|December 21, 2020
Rapid EGFR Mutation Detection Using the Idylla Platform: Single-Institution Experience of 1200 Cases Analyzed by an In-House Developed Pipeline and Comparison with Concurrent Next-Generation Sequencing ResultsAmir Momeni-Boroujeni, Paulo Salazar, Tao Zheng, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 7, 2025
Low-Grade Fibro-Osseous Lesions With Isolated Chromosome 12 Chromothripsis: A Distinct Entity Or a Low-Grade Central Osteosarcoma With a Novel Driver?Carla Saoud, Yanming Zhang, Jamal Benhamida, et al.
Genes, Chromosomes & Cancer|June 6, 2022
EWSR1::YY1 fusion positive peritoneal epithelioid mesothelioma harbors mesothelioma epigenetic signature: Report of 3 cases in support of an emerging entityJosephine K Dermawan, Dianne Torrence, Cheng-Han Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 29, 2025
Methylation Analysis Reveals Epigenetic Congruence Between Bone Sarcomas With H3-3A Mutations and Malignant Giant Cell Tumors of BoneCarla Saoud, Jamal Benhamida, Laetitia Borsu, et al.
Cancer Research Communications|March 17, 2023
Distinct IDH1/2-associated Methylation Profile and Enrichment of <i>TP53</i> and <i>TERT</i> Mutations Distinguish Dedifferentiated Chondrosarcoma from Conventional ChondrosarcomaJosephine Kam Tai Dermawan, Khedoujia Nafa, Abhinita Mohanty, et al.
Human Pathology|April 26, 2017
Pericytic tumors of the kidney-a clinicopathologic analysis of 17 casesDeepika Sirohi, Steven C Smith, Jonathan I Epstein, et al.
Cancer Research|January 16, 2019
Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase FusionsEmiliano Cocco, Jamal Benhamida, Sumit Middha, et al.
The Journal of Molecular Diagnostics : JMD|December 16, 2023
Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell NeoplasmsYing Liu, Caleb Ho, Wayne Yu, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Diagnostic Pathology|June 27, 2019
Validation of mitotic cell quantification via microscopy and multiple whole-slide scannersKazuhiro Tabata, Naohiro Uraoka, Jamal Benhamida, et al.
Genome Research|April 23, 2008
Comparative proteogenomics: combining mass spectrometry and comparative genomics to analyze multiple genomesNitin Gupta, Jamal Benhamida, Vipul Bhargava, et al.
The Journal of Molecular Diagnostics : JMD|December 21, 2020
Rapid EGFR Mutation Detection Using the Idylla Platform: Single-Institution Experience of 1200 Cases Analyzed by an In-House Developed Pipeline and Comparison with Concurrent Next-Generation Sequencing ResultsAmir Momeni-Boroujeni, Paulo Salazar, Tao Zheng, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 7, 2025
Low-Grade Fibro-Osseous Lesions With Isolated Chromosome 12 Chromothripsis: A Distinct Entity Or a Low-Grade Central Osteosarcoma With a Novel Driver?Carla Saoud, Yanming Zhang, Jamal Benhamida, et al.
Genes, Chromosomes & Cancer|June 6, 2022
EWSR1::YY1 fusion positive peritoneal epithelioid mesothelioma harbors mesothelioma epigenetic signature: Report of 3 cases in support of an emerging entityJosephine K Dermawan, Dianne Torrence, Cheng-Han Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 29, 2025
Methylation Analysis Reveals Epigenetic Congruence Between Bone Sarcomas With H3-3A Mutations and Malignant Giant Cell Tumors of BoneCarla Saoud, Jamal Benhamida, Laetitia Borsu, et al.
Cancer Research Communications|March 17, 2023
Distinct IDH1/2-associated Methylation Profile and Enrichment of <i>TP53</i> and <i>TERT</i> Mutations Distinguish Dedifferentiated Chondrosarcoma from Conventional ChondrosarcomaJosephine Kam Tai Dermawan, Khedoujia Nafa, Abhinita Mohanty, et al.
Human Pathology|April 26, 2017
Pericytic tumors of the kidney-a clinicopathologic analysis of 17 casesDeepika Sirohi, Steven C Smith, Jonathan I Epstein, et al.
Cancer Research|January 16, 2019
Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase FusionsEmiliano Cocco, Jamal Benhamida, Sumit Middha, et al.
The Journal of Molecular Diagnostics : JMD|December 16, 2023
Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell NeoplasmsYing Liu, Caleb Ho, Wayne Yu, et al.
Pageof 4